Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement
Article Dans Une Revue Gut Année : 2022

Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target

Anne Fougerat
Yannick Lippi
Marion Régnier
  • Fonction : Auteur
  • PersonId : 1073447
Alexia Laroyenne
  • Fonction : Auteur
Muhammad Arif
  • Fonction : Auteur
  • PersonId : 776450
  • IdRef : 199613680
Frédéric Lasserre
  • Fonction : Auteur
  • PersonId : 1202853
Alain Marrot
  • Fonction : Auteur
Talal Al Saati
  • Fonction : Auteur
Caroline Sommer
  • Fonction : Auteur
Claire Naylies
  • Fonction : Auteur
  • PersonId : 1041410
Céline Lukowicz
  • Fonction : Auteur
  • PersonId : 1017606
Nicolas Loiseau
Catherine Postic
  • Fonction : Auteur

Résumé

Objective We evaluated the influence of sex on the pathophysiology of non-alcoholic fatty liver disease (NAFLD). We investigated diet-induced phenotypic responses to define sex-specific regulation between healthy liver and NAFLD to identify influential pathways in different preclinical murine models and their relevance in humans. Design Different models of diet-induced NAFLD (high-fat diet, choline-deficient high-fat diet, Western diet or Western diet supplemented with fructose and glucose in drinking water) were compared with a control diet in male and female mice. We performed metabolic phenotyping, including plasma biochemistry and liver histology, untargeted large-scale approaches (liver metabolome, lipidome and transcriptome), gene expression profiling and network analysis to identify sex-specific pathways in the mouse liver. Results The different diets induced sex-specific responses that illustrated an increased susceptibility to NAFLD in male mice. The most severe lipid accumulation and inflammation/fibrosis occurred in males receiving the high-fat diet and Western diet, respectively. Sex-biased hepatic gene signatures were identified for these different dietary challenges. The peroxisome proliferator-activated receptor α (PPARα) co-expression network was identified as sexually dimorphic, and in vivo experiments in mice demonstrated that hepatocyte PPARα determines a sex-specific response to fasting and treatment with pemafibrate, a selective PPARα agonist. Liver molecular signatures in humans also provided evidence of sexually dimorphic gene expression profiles and the sex-specific co-expression network for PPARα. Conclusions These findings underscore the sex specificity of NAFLD pathophysiology in preclinical studies and identify PPARα as a pivotal, sexually dimorphic, pharmacological target. Trial registration number NCT02390232 .
Fichier principal
Vignette du fichier
Smati et al - 2021 - Integrative study of diet-induced mouse models.pdf (149.67 Mo) Télécharger le fichier
Supplementary File 1 methods clean.pdf (145.9 Ko) Télécharger le fichier
Supplementary figures.pdf (128.77 Mo) Télécharger le fichier
Supplementary tables.pdf (220.18 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03215969 , version 1 (11-05-2022)

Licence

Identifiants

Citer

Sarra Smati, Arnaud Polizzi, Anne Fougerat, Sandrine Ellero-Simatos, Yuna Blum, et al.. Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target. Gut, 2022, 71 (4), pp.807-821. ⟨10.1136/gutjnl-2020-323323⟩. ⟨hal-03215969⟩
2338 Consultations
813 Téléchargements

Altmetric

Partager

More